The wayback machine...
This line is from Nasdaq historical quotes:
09/14/2009 0.1195 0.1195 0.0951 0.098 79,239,816
That was the end of day on 14 Sept 2009 (~.12).
I have tried to find the historical Authorized and Outstanding shares for that date but was unable. If memory serves correctly, it was 4 - 4.5 billion.
Back then google had a finance message board, yahoo's still sucked, and everyone was high on the prospect of BIEL getting FDA approval. Biel had recently received their patents.
I just want to remind everyone that BIEL reached ~.12 on the pure speculation that it would get FDA apporval. 4.5 billion shares at .12 put BIEL at 540000000 value that day. BIEL had none of the retail agreements or approvals (and, likely, future approvals) it now has.
It seems to me that it takes a particularly short-sighted individual to not believe BIEL, even with 20 billion authorized shares, couldn't reach an equivalent valuation. At .03 BIEL would be valued at 600000000. VYGR, UPLD, PNQI, ADRO, PUB, ADUS, and SPAR are other companies values around 600000000 according to Nasdaq. Check them out and come back and tell us why BIEL isn't more marketable than any off them. Getting rid of pain pays.
Major investment companies can't touch BIEL yet. I predict that, once the remaining FDA approvals come through and BIEL is actually being advertised, the company will do a 100/1 RS at somewhere between .03 and .05. BIEL will uplist and become available to investment firms and that is when the real take off will happen.
